GCGJ
0.5200
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
-P/E (TTM)
-Basic EPS (TTM)
-0.01Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Guochun International posted zero revenues for Q3 ended September 30, 2025, with operating expenses jumping to $25,347 (up from $6,844 y/y, derived), driving a $25,347 operating loss—worse than last year's $6,844, fueled by higher professional fees. Nine-month net loss widened to $37,863 from $23,941 y/y (derived), matching operating loss with no other items. Cash stayed at $0, propped by $500 officer advance covering minor operating outflow; liabilities hit $92,475, all current. EPS checks out at $(0.01) on 3,870,600 diluted shares. Disclosure controls remain ineffective. Still hunting acquisitions. Material weaknesses persist.
10-Q
Q2 FY2025 results
Guochun International posted zero revenues for Q2 ended June 30, 2025, with operating expenses climbing to $11,622 from $5,603 y/y, driven by higher professional fees, yielding a $11,622 net loss versus $5,603 prior year. YTD through June 30, operating loss narrowed to $12,516 from $17,097 y/y as expenses fell. No cash on hand; $500 net cash used in operations offset by officer advances, liabilities at $67,128. EPS holds at $(0.00) across 3,870,600 diluted shares. Disclosure controls ineffective due to material weaknesses. Still hunting acquisitions. Going concern in doubt.
10-Q
Q1 FY2025 results
Guochun International posted no revenue and a slim $894 operating loss for Q1 ended March 31, 2025, down sharply y/y from $11,494 as professional fees vanished. Expenses dropped to other general and administrative at $894, matching accounts payable growth for breakeven cash use. No assets or cash; liabilities ticked to $55,506 on $45,528 due to sole officer. Stockholders' deficit widened to match. Material weaknesses persist in controls. Searching for acquisitions. No litigation. Going concern in doubt.
10-K
FY2024 results
Guochun International posted FY2024 net loss of $26,585, up from $22,947 in FY2023, on zero revenue and $26,585 operating expenses—mainly audit and filing fees—versus $22,947 prior year. No Q4 breakdowns disclosed. Cash stayed at zero, funded by $18,495 director advances, down from $23,675. No employees, no assets, just hunting acquisitions. Shell with weak controls. No guidance. COVID resurgences threaten deal flow.
10-Q
Q3 FY2024 results
Guochun International posted zero revenues for Q3 ended September 30, 2024, with operating loss widening 10.6% y/y to $6,844 from $6,194, driven by higher professional fees; nine-month operating loss climbed 36.4% y/y to $23,941 (derived). No gross margins or EPS deltas apply amid inactivity. Cash stayed at $0, fully funded by $18,495 in officer advances matching operating cash burn, while liabilities hit $51,968 and stockholders' deficit deepened. Still hunting acquisitions. Disclosure controls ineffective due to material weaknesses.
AFJK
Aimei Health Technology Co., Lt
26.96-3.55
AGLY
Atlantis Glory Inc.
0.02+0.00
CBGGF
Chain Bridge I
10.91+0.00
CGCT
Cartesian Growth Corporation II
10.11+0.00
CLUS
-
200.00+0.00
CWNOF
CHINESEWORLDNET.COM INC
0.01+0.00
EEGI
Eline Entertainment Group, Inc.
0.00+0.00
GSRT
GSR III Acquisition Corp.
15.52+1.00
UHGI
Ultimate Holdings Group, Inc.
1.00+0.00
VACH
Voyager Acquisition Corp
10.57+0.00